Skip to main content

Articles

Page 6 of 70

  1. Stereotactic radiosurgery (SRS) is the preferred treatment for vestibular schwannoma (VS) in patients with preserved hearing and tumour diameter < 3 cm. Emerging evidence suggests restricting cochlear dose cou...

    Authors: Jeremy Khong, Ramkumar Govindaraj, Daniel Ramm, Suzanne Edwards and Daniel Roos
    Citation: Radiation Oncology 2023 18:2
  2. Perirectal spacers may be beneficial to reduce rectal side effects from radiotherapy (RT). Here, we present the impact of a hyaluronic acid (HA) perirectal spacer on rectal dose as well as spacer stability, lo...

    Authors: Ulrika Björeland, Kristina Notstam, Per Fransson, Karin Söderkvist, Lars Beckman, Joakim Jonsson, Tufve Nyholm, Anders Widmark and Camilla Thellenberg Karlsson
    Citation: Radiation Oncology 2023 18:1
  3. The study objective was to validate the relative biological effectiveness (RBE) in RayStation for carbon-ion radiotherapy (CIRT) using the Syngo treatment planning system as reference.

    Authors: Weiwei Wang, Zhijie Huang, Wei Sun, Xufei Wang, Jingfang Zhao and Hao Shen
    Citation: Radiation Oncology 2022 17:219
  4. We evaluated and compared the efficacy and safety of chemotherapy with paclitaxel plus cisplatin (TP) or carboplatin (TC) in patients with locally advanced esophageal squamous cell carcinoma (LA-ESCC) who unde...

    Authors: Li Jiang, Jie Zhu, Xue Chen, Yi Wang, Lei Wu, Gang Wan, Yongtao Han, Xuefeng Leng, Lin Peng and Qifeng Wang
    Citation: Radiation Oncology 2022 17:218

    The Correction to this article has been published in Radiation Oncology 2023 18:75

  5. Resistance to conventional dose schemes and radiotoxicity of healthy tissue is a clinical challenge in the radiation therapy of large locally advanced drug-resistant gastrointestinal stromal tumor (LADR-GIST)....

    Authors: Haixia Cui, Ying Li, Wei Huang, Wenli Lu and Xin Yi
    Citation: Radiation Oncology 2022 17:216
  6. The safety of an MRI simulation-guided boost after short-course preoperative radiotherapy (SCPRT) for unresectable rectal cancer is assessed with a planned interim analysis.

    Authors: Wen-Yang Liu, Jin-Ming Shi, Ning Li, Xin Wang, Yuan-Hong Gao, Yihebali Chi, Yong-Kun Sun, Qing Zhao, Yong-Jian Zhu, Hong-Da Chen, Hui Fang, Ning-Ning Lu, Shu-Nan Qi, Bo Chen, Shu-Lian Wang, Yong-Wen Song…
    Citation: Radiation Oncology 2022 17:214
  7. Linac-based fractionated stereotactic radiotherapy (fSRT) and stereotactic radiosurgery (SRS) are increasingly being used to manage patients with multiple metastases. This retrospective cohort study aimed to c...

    Authors: Masanori Hirata, Kazuaki Yasui, Naofumi Oota, Hirofumi Ogawa, Tsuyoshi Onoe, Sayo Maki, Yusuke Ito, Kenji Hayashi, Hirofumi Asakura, Shigeyuki Murayama, Koichi Mitsuya, Shoichi Deguchi, Katsumasa Nakamura, Nakamasa Hayashi, Tetsuo Nishimura and Hideyuki Harada
    Citation: Radiation Oncology 2022 17:213

    The Correction to this article has been published in Radiation Oncology 2023 18:45

  8. To construct machine learning models for predicting progression free survival (PFS) and overall survival (OS) with esophageal squamous cell carcinoma (ESCC) patients.

    Authors: Yongbin Cui, Zhengjiang Li, Mingyue Xiang, Dali Han, Yong Yin and Changsheng Ma
    Citation: Radiation Oncology 2022 17:212
  9. Standard therapy for localized high-risk soft tissue sarcoma includes surgical resection and neoadjuvant or adjuvant radiation therapy (± chemotherapy and locoregional hyperthermia). No difference in oncologic...

    Authors: Vlatko Potkrajcic, Jonas Kolbenschlag, Saskia Sachsenmaier, Adrien Daigeler, Ruth Ladurner, Alexander Golf, Cihan Gani, Daniel Zips, Frank Paulsen and Franziska Eckert
    Citation: Radiation Oncology 2022 17:210
  10. Human papillomavirus (HPV)-positive tonsil cancer has a better prognosis than HPV-negative tonsil cancer. Deintensification strategies to reduce or avoid radiotherapy (RT) for patients with HPV-associated tons...

    Authors: Joongyo Lee, Kangpyo Kim, Kyung Hwan Kim, Ki Chang Keum, Hye Ryun Kim, Min Hee Hong, Eun Chang Choi, Se-Heon Kim, Yoon Woo Koh and Chang Geol Lee
    Citation: Radiation Oncology 2022 17:209
  11. To segment the pelvic active bone marrow (PABM) using magnetic resonance (MR) functional imaging and investigate the feasibility and dosimetric characteristics of cervical cancer proton radiotherapy for active...

    Authors: Xiaohang Qin, Guanzhong Gong, Lizhen Wang, Ya Su and Yong Yin
    Citation: Radiation Oncology 2022 17:207
  12. High-dose-rate (HDR) intracavitary-interstitial brachytherapy (IC-ISBT) is an effective treatment for bulky, middle, and advanced cervical cancer. In this study, we compared the differences between 60Co and 19...

    Authors: Aiping Wen, Xianliang Wang, Bingjie Wang, Chuanjun Yan, Jingyue Luo, Pei Wang and Jie Li
    Citation: Radiation Oncology 2022 17:206
  13. The goal of this study is to validate different CBCT correction methods to select the superior method that can be used for dose evaluation in breast cancer patients with large anatomical changes treated with p...

    Authors: Vincent C. Hamming, Sebastian Andersson, John H. Maduro, Johannes A. Langendijk, Stefan Both and Nanna M. Sijtsema
    Citation: Radiation Oncology 2022 17:205
  14. Dose escalation in prostate radiotherapy (RT) have led to improved biochemical controls and reduced the risk of distant metastases. Over the past three decades, despite technological advancements in RT plannin...

    Authors: Hamed Ghaffari and Arezoo Mehrabian
    Citation: Radiation Oncology 2022 17:204
  15. For patients with a higher burden of localized prostate cancer, radiation dose escalation with brachytherapy boosts have improved cancer control outcomes at the cost of urinary toxicity. We hypothesize that a ...

    Authors: C. Belliveau, M. Barkati, G. Delouya, D. Taussky, M. C. Beauchemin, C. Lambert, L. Beaulieu, D. Beliveau-Nadeau, B. Nicolas, J. F. Carrier, E. Vigneault and C. Ménard
    Citation: Radiation Oncology 2022 17:203
  16. The aim of this study was to develop a normal tissue complication probability model using a machine learning approach (ML-based NTCP) to predict the risk of radiation-induced liver disease in hepatocellular ca...

    Authors: Anussara Prayongrat, Natchalee Srimaneekarn, Kanokporn Thonglert, Chonlakiet Khorprasert, Napapat Amornwichet, Petch Alisanant, Hiroki Shirato, Keiji Kobashi and Sira Sriswasdi
    Citation: Radiation Oncology 2022 17:202

    The Correction to this article has been published in Radiation Oncology 2023 18:53

  17. The prognosis of recurrent glioblastoma (GBM) is poor, with limited options of palliative localized or systemic treatments. Survival can be improved by a second localized treatment; however, it is not currentl...

    Authors: Nicolas Demogeot, J. Salleron, F. Rech, L. Taillandier, P. Royer and G. Vogin
    Citation: Radiation Oncology 2022 17:201
  18. To analyze RapidPlan knowledge-based models for DVH estimation of organs at risk from breast cancer VMAT plans presenting arc sectors en-face to the breast with zero dose rate, feature imposed during the optim...

    Authors: Antonella Fogliata, Sara Parabicoli, Lucia Paganini, Giacomo Reggiori, Francesca Lobefalo, Luca Cozzi, Ciro Franzese, Davide Franceschini, Ruggero Spoto and Marta Scorsetti
    Citation: Radiation Oncology 2022 17:200
  19. Due to the increasing expertise in transoral laser surgery and image-guided radiation therapy, treatment outcomes have recently improved in patients with early-stage glottic cancer. The objective of the curren...

    Authors: Thomas Held, Henrik Franke, Kristin Lang, Tanja Eichkorn, Sebastian Regnery, Katharina Weusthof, Lukas Bauer, Karim Plath, Gerhard Dyckhoff, Peter K. Plinkert, Semi B. Harrabi, Klaus Herfarth, Jürgen Debus and Sebastian Adeberg
    Citation: Radiation Oncology 2022 17:199
  20. Quantitative image analysis based on radiomic feature extraction is an emerging field for survival prediction in oncological patients. 18F-Fluorethyltyrosine positron emission tomography (18F-FET PET) provides im...

    Authors: Tun Wiltgen, Daniel F. Fleischmann, Lena Kaiser, Adrien Holzgreve, Stefanie Corradini, Guillaume Landry, Michael Ingrisch, Ilinca Popp, Anca L. Grosu, Marcus Unterrainer, Peter Bartenstein, Katia Parodi, Claus Belka, Nathalie Albert, Maximilian Niyazi and Marco Riboldi
    Citation: Radiation Oncology 2022 17:198
  21. Although postoperative radiotherapy (PORT) is demonstrably effective in local control of head and neck adenoid cystic carcinoma (HNACC), its application is controversial and the subset of patients who would be...

    Authors: Seo Hee Choi, Andrew Jihoon Yang, Sun Och Yoon, Hye Ryun Kim, Min Hee Hong, Se-Heon Kim, Eun Chang Choi, Ki Chang Keum and Chang Geol Lee
    Citation: Radiation Oncology 2022 17:197
  22. Cancer has always been a worldwide problem, and the application of radiotherapy has greatly improved the survival rate of cancer patients. Radiotherapy can modulate multiple cell fate decisions to kill tumor c...

    Authors: Haoran Chen, Zhongyu Han, Qian Luo, Yi Wang, Qiju Li, Lisui Zhou and Houdong Zuo
    Citation: Radiation Oncology 2022 17:196
  23. Total body irradiation (TBI)-based-conditioning before allogeneic hematopoietic stem cell transplantation (allo-HSCT) is standard of care in patients with acute myeloid leukemia (AML) but can cause long-term m...

    Authors: Isabella Gruber, Oliver Koelbl, Wolfgang Herr, Ernst Holler, Matthias Edinger and Daniel Wolff
    Citation: Radiation Oncology 2022 17:195
  24. Malignant melanoma constitutes an aggressive tumor of the skin, the pathogenesis of which is influenced by immunological processes. In this context, the influence of radiotherapy (RT) on inflammatory markers h...

    Authors: Michael Oertel, Katrin Borrmann, Andrea Baehr, Hans Theodor Eich and Burkhard Greve
    Citation: Radiation Oncology 2022 17:194
  25. Dose painting planning would be more complicated due to different levels of prescribed doses and more complex evaluation with conventional plan quality indices considering uniform dose prescription. Therefore,...

    Authors: Saman Moradi, Bijan Hashemi, Mohsen Bakhshandeh, Amin Banaei and Bahram Mofid
    Citation: Radiation Oncology 2022 17:193
  26. Authors: Johannes Kraft, Stefan Weick, Kathrin Breuer, Paul Lutyj, Klaus Bratengeier, Florian Exner, Anne Richter, Jörg Tamihardja, Dominik Lisowski, Bülent Polat and Michael Flentje
    Citation: Radiation Oncology 2022 17:192
  27. Esophagectomy is the standard adjuvant treatment for superficial esophageal squamous cell carcinoma (SESCC) following noncurative endoscopic submucosal dissection (ESD). However, recent reports have also shown...

    Authors: Gen Suzuki, Hideya Yamazaki, Norihiro Aibe, Koji Masui, Takuya Kimoto, Shinsuke Nagasawa, Shou Watanabe, Shou Seri, Akito Asato, Atsushi Shiozaki, Hitoshi Fujiwara, Hirotaka Konishi, Osamu Dohi, Takeshi Ishikawa, Hany Elsaleh and Kei Yamada
    Citation: Radiation Oncology 2022 17:191
  28. Malignant peripheral nerve sheath tumors (MPNST) are sarcomas that arise from peripheral nerves. They generally have a poor prognosis which is exacerbated by high local recurrence rates. This case report discu...

    Authors: Edwin Chaharbakhshi, Joshua Hardham, Ramon Alfredo Siochi, Todd C. Tenenholz and Brock A. Lindsey
    Citation: Radiation Oncology 2022 17:190
  29. This study introduces innovative strategies, the doublet regimen of concurrent chemoradiotherapy, to ensure longer survival for locoregionally advanced nasopharyngeal carcinoma.

    Authors: Zhi-Qiang Wang, Xu-Dong Feng, Chun-Lei Ge, Yi Yang, Na Liang, Qing Ye, Yang Fu, Jian Wei, Yong Zhang and Rong-Qing Li
    Citation: Radiation Oncology 2022 17:189
  30. This study was designed to establish radiation pneumonitis (RP) prediction models using dosiomics and/or deep learning-based radiomics (DLR) features based on 3D dose distribution.

    Authors: Ying Huang, Aihui Feng, Yang Lin, Hengle Gu, Hua Chen, Hao Wang, Yan Shao, Yanhua Duan, Weihai Zhuo and Zhiyong Xu
    Citation: Radiation Oncology 2022 17:188
  31. Present studies on the efficacy and safety of curative chemoradiation therapy (CRT) with esophageal cancer reflect heterogenous results especially in elderly patients. The aim of this study was to evaluate the...

    Authors: Philipp Linde, Markus Mallmann, Anne Adams, Simone Wegen, Johannes Rosenbrock, Maike Trommer, Simone Marnitz, Christian Baues and Eren Celik
    Citation: Radiation Oncology 2022 17:187
  32. The Korean Radiation Oncology Group (KROG) 19 − 09 prospective cohort study aims to determine the effect of regional nodal irradiation on regional recurrence rates in ypN0 breast cancer patients. Dosimetric va...

    Authors: Myeongsoo Kim, Boram Park, Haksoo Kim, Yeon-Joo Kim, Dong Ju Choi, Weonkuu Chung, Yeon Joo Kim, Hyun Soo Shin, Jung Ho Im, Chang-Ok Suh, Jin Hee Kim, Boram Ha, Mi Young Kim, Jongmoo Park, Jeongshim Lee, Sung-Ja Ahn…
    Citation: Radiation Oncology 2022 17:186
  33. Monte Carlo simulation is considered as the most accurate method for dose calculation in radiotherapy. PRIMO is a Monte-Carlo program with a user-friendly graphical interface.

    Authors: Yang Li, Xingru Sun, Ying Liang, Yuchao Hu and Chenbin Liu
    Citation: Radiation Oncology 2022 17:185
  34. Definitive concurrent chemoradiotherapy (CCRT) is the standard treatment for locally advanced non-small cell lung cancer (LANSCLC) patients, but the treatment response and survival outcomes varied among these ...

    Authors: Nai-Bin Chen, Mai Xiong, Rui Zhou, Yin Zhou, Bo Qiu, Yi-Feng Luo, Su Zhou, Chu Chu, Qi-Wen Li, Bin Wang, Hai-Hang Jiang, Jin-Yu Guo, Kang-Qiang Peng, Chuan-Miao Xie and Hui Liu
    Citation: Radiation Oncology 2022 17:184
  35. The DNA damage response (DDR) is a mechanism that protects cells against radiation-induced oxidative DNA damage by causing cell cycle arrest and apoptosis. TP63 is a member of the tumour suppressor TP53 gene fami...

    Authors: Ken-ichi Kudo, Naohiro Tsuyama, Kento Nagata, Tatsuhiko Imaoka, Daisuke Iizuka, Misaki Sugai-Takahashi, Moe Muramatsu and Akira Sakai
    Citation: Radiation Oncology 2022 17:183
  36. Artificial intelligence (AI) algorithms are capable of automatically detecting contouring boundaries in medical images. However, the algorithms impact on clinical practice of cervical cancer are unclear. We ai...

    Authors: Shihong Nie, Yuanfeng Wei, Fen Zhao, Ya Dong, Yan Chen, Qiaoqi Li, Wei Du, Xin Li, Xi Yang and Zhiping Li
    Citation: Radiation Oncology 2022 17:182
  37. Tumor-infiltrating lymphocytes (TILs) are associated with locoregional control (LRC) in head-and-neck squamous cell carcinoma (HNSCC) patients undergoing (chemo)radiotherapy. As immunosenescence results in red...

    Authors: Alexander Rühle, Jovan Todorovic, Simon S. K. Spohn, Eleni Gkika, Christoph Becker, Andreas Knopf, Constantinos Zamboglou, Tanja Sprave, Martin Werner, Anca-Ligia Grosu, Gian Kayser and Nils H. Nicolay
    Citation: Radiation Oncology 2022 17:181
  38. The aim of this work was to determine whether patients with intermediate-risk head and neck squamous cell carcinoma (HNSCC) can benefit from postoperative chemoradiotherapy (POCRT).

    Authors: Zhi-Qiao Liu, Pu-Yun OuYang, Bao-Yu Zhang, En-Ni Chen, Su-Ming Xiao, Shan-Shan Yang, Zhong-Yuan Yang and Fang-Yun Xie
    Citation: Radiation Oncology 2022 17:180
  39. This systematic review aims to synthesise the outcomes of different strategies of incorporating functional biological markers in the radiation therapy plans of patients with glioblastoma to support clinicians ...

    Authors: John T Ryan, Masao Nakayama, Ian Gleeson, Liam Mannion, Moshi Geso, Jennifer Kelly, Sweet Ping Ng and Nicholas Hardcastle
    Citation: Radiation Oncology 2022 17:178
  40. Based on a previous study on the feasibility of TomoEQA, an exit detector-based patient-specific pre-treatment quality assurance (QA) method for helical tomotherapy, an in-depth clinical evaluation was conducted.

    Authors: Changhwan Kim, Min Cheol Han, Young Kyu Lee, Han-Back Shin, Hojin Kim and Jin Sung Kim
    Citation: Radiation Oncology 2022 17:177
  41. To assess the effectiveness and toxicity of radiation dose escalation for locally advanced nasopharyngeal carcinoma (LA-NPC) in patients with local and/or regional residual lesion(s) after standard treatment.

    Authors: Ting Jin, Nan-Fang Liu, Qi-Feng Jin, Yong-Hong Hua and Xiao-Zhong Chen
    Citation: Radiation Oncology 2022 17:176
  42. Radiotherapy is one of the effective ways to treat glioblastoma multiforme (GBM). We aimed to explore the prognostic difference between external beam radiotherapy (EBRT) and EBRT combined with brachytherapy (E...

    Authors: Kai Yang, Yan Ma, Guo Chen, Shaojie Zeng, Ting Guo and Zelong Yang
    Citation: Radiation Oncology 2022 17:174
  43. Localized pancreatic adenocarcinoma carries a poor prognosis even after aggressive therapy. Up to 40% of patients may develop locoregional disease as the first site of failure. As such, there may be a role for...

    Authors: Abhinav V. Reddy, Colin S. Hill, Lei Zheng, Jin He and Amol K. Narang
    Citation: Radiation Oncology 2022 17:173

Annual Journal Metrics

  • 2022 Citation Impact
    3.6 - 2-year Impact Factor
    3.8 - 5-year Impact Factor
    1.370 - SNIP (Source Normalized Impact per Paper)
    1.037 - SJR (SCImago Journal Rank)

    2023 Speed
    16 days submission to first editorial decision for all manuscripts (Median)
    132 days submission to accept (Median)

    2023 Usage 
    1,958,690 downloads
    605 Altmetric mentions